Retinoid X Receptor alpha antibody (AA 38-87)
Quick Overview for Retinoid X Receptor alpha antibody (AA 38-87) (ABIN6737742)
Target
See all Retinoid X Receptor alpha (RXRA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 38-87
-
Specificity
- Human RXRA
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human, Rat, Guinea pig (100%).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide located between aa38-87 of human RXRA (P19793, NP_002948). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset, Mouse, Rat, Elephant, Bat, Horse, Guinea pig (100%), Opossum (91%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:312500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody.
Not recommended for: IHC-P -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Distilled Water.
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- Retinoid X Receptor alpha (RXRA) (Retinoid X Receptor, alpha (RXRA))
-
Alternative Name
- RXTA / RXR-alpha
-
Background
-
Name/Gene ID: RXRA
Subfamily: NR2 Hepatocyte NF4-like
Family: NHR
Synonyms: RXRA, RXR-alpha, NR2B1, Retinoid X receptor alpha, Retinoid X receptor, alpha -
Gene ID
- 6256
-
NCBI Accession
- NP_002948
-
UniProt
- P19793
-
Pathways
- Nuclear Receptor Transcription Pathway, Retinoic Acid Receptor Signaling Pathway, Steroid Hormone Mediated Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha, Hepatitis C
Target
-